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1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: Bacteremia in dengue may occur with common exposure to
pathogens in association with severe organ impairment or severe dengue, which may result
in death. Cohort studies identifying risk factors for concurrent bacteremia among patients with
dengue are rare.
Methods: We conducted a retrospective caseecontrol study of adult patients with dengue who
were admitted to the Department of Infectious Diseases at Tan Tock Seng Hospital, Singapore
from 2004 to 2008. For each case of dengue with concurrent bacteremia (within the first 72
hours of admission), we selected four controls without bacteremia, who were matched on year
of infection and dengue confirmation method. Conditional logistic regression was performed to
identify risk factors for concurrent bacteremia.
Results: Among 9,553 patients with dengue, 29 (0.3%) had bacteremia. Eighteen of these pa-
tients (62.1%) had concurrent bacteremia. The predominant bacteria were Staphylococcus
aureus, one of which was a methicillin-resistant strain. Dengue shock syndrome occurred more
frequently and hospital stay was longer among cases than among controls. Three cases did not
survive, whereas none of the controls died. In multivariate analysis, being critically ill atble Disease Center, Institute of Infectious Diseases and Epidemiology, Department of Infectious Dis-
an Tan Tock Seng, Singapore 308433, Singapore.
tsh.com.sg (T.-L. Thein).
to this manuscript.
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Microbiology, Immunology and Infecthospital presentation was independently associated with 15 times the likelihood of a patient
with dengue having concurrent bacteremia.
Conclusion: Concurrent bacteremia in adult patients with dengue is uncommon but presents
atypically and results in more deaths and longer hospital stay. Given the associated mortality,
collection of blood cultures and empiric antibiotic therapy may be considered in patients who
are critically ill.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Dengue is an arbovirus-borne infection that is widespread in
tropical and subtropical regions.1 A recent model by Bhatt
et al2 estimated that 390 million infections occur annually,
with 96 million of these infections being clinically
apparent. Despite the high rate of infection worldwide,
there is no effective vaccine against dengue.3,4 Clinical
manifestations of dengue range from an asymptomatic
infection to a mild, flu-like, self-limiting infection.5 In
adults, the infection can less commonly develop into the
more severe and life-threatening forms, dengue hemor-
rhagic fever (DHF) and dengue shock syndrome (DSS). Close
monitoring and timely administration of fluid therapy have
improved outcomes from DHF and DSS globally.5,6 More
recently, the World Health Organization (WHO) proposed a
new classification that better guides clinical management:
dengue with warning signs, dengue without warning signs,
and severe dengue.5,7
Only a few case series of concurrent bacteremia and
dengue infection have been reported. Bacteremia in
dengue may occur with common exposure to pathogens8,9
in association with severe organ impairment10 or severe
dengue, resulting in death.11e13 In addition, nosocomial
infection may result from prolonged hospitalization for
severe dengue and its complications.11 Hypotheses on
the pathogenesis of concurrent bacteremia in patients
with dengue include disintegration of endothelial cells by
antibodies against dengue nonstructural protein 114,15
and/or relative immunosuppression in patients with
dengue.11
A recent cohort study was carried out by Lee et al16 to
identify the clinical characteristics and risk factors of pa-
tients with DHF and concurrent bacteremia. However, large
cohort studies identifying risk factors for patients with
dengue and concurrent bacteremia are rare. In this large
cohort study of adult patients with dengue who were
admitted to the Department of Infectious Diseases at Tan
Tock Seng Hospital (TTSH), Singapore from 2004 to 2008, we
aimed to (1) determine the prevalence of concurrent
bacteremia in adult patients with dengue; (2) describe the
clinical characteristics of adult patients with dengue and
concurrent bacteremia; and (3) identify clinical and labo-
ratory risk factors for concurrent bacteremia at the time of
hospital presentation. This information would be clinically
useful for doctors performing appropriate microbiological
investigations of bacteremia and starting early empiric
antibiotic therapy.hein T-L, et al., Risk factors for
ion (2015), http://dx.doi.org/10.Methods
Patients
We conducted a retrospective study of laboratory-
diagnosed dengue in adult patients who were admitted to
the Department of Infectious Diseases at TTSH from
January 1, 2004, to December 31, 2008.
Patients were diagnosed as having probable dengue
based on the 1997 and 2009 WHO guidelines.5,17 Dengue
Real-time Reverse Transcription-Polymerase Chain Reac-
tion, as described earlier,18 or Panbio Rapid Dengue Duo
Rapid Strip Test (Panbio Diagnostic, Queensland,
Australia)19,20 was performed at the Department of Labo-
ratory Medicine, TTSH, according to the manufacturer’s
instructions, to confirm the diagnosis. Diagnosis of bacter-
emia was confirmed by a positive bacterial culture in the
patient’s blood sample obtained after admission to the
hospital. In this study, “concurrent bacteremia” was
defined as a positive bacterial blood culture within 72 hours
of a patient’s admission.16 Blood culture was taken in the
event of clinical deterioration despite treatment based on a
standardized dengue care path.
For each case of dengue with concurrent bacteremia, we
selected four controls among patients with dengue without
clinical suspicion of bacteremia or without blood cultures
collected or reported as negative by the Department of
Laboratory Medicine, TTSH, matched on year of infection (a
surrogate for predominant circulating dengue serotype) and
dengue confirmation method. The selection generated all
controls without collection of blood cultures. In brief, 29
patients had bacteremia from 2004 to 2008, among which
18 had blood samples collected for bacterial culture within
72 hours of admission. Although the other 11 patients
yielded positive results for bacterial growth, blood samples
were collected >72 hours after admission. Therefore, it
was not possible to determine whether bacteremia was
concurrent with dengue infection or was acquired nosoco-
mially. An analysis identifying risk factors was carried out
with 72 controls and 18 cases.
Demographics (age, sex, and ethnicity), comorbidities
(diabetes mellitus, hypertension, hyperlipidemia, and car-
diac diseases), dengue diagnosis classification, symptoms
and signs at presentation (Table 1), parameters for labo-
ratory investigation at presentation, types of intervention,
dengue severity classification at hospital discharge, and
clinical outcomes (Table 2) were extracted for comparison
between cases and controls. The laboratory parametersconcurrent bacteremia in adult patients with dengue, Journal of
1016/j.jmii.2015.06.008
Table 1 Demographics, comorbidities, dengue diagnosis, and signs and symptoms of cases and controls at presentationa
Variable Cases (n Z 18) Controls (n Z 72) p
Demographics
Age (y) 38.5 (21e93) 36 (17e59.05) NS
Male 11 (61.1) 50 (69.4) NS
Chinese ethnicity 14 (77.8) 55 (76.4) NS
Comorbidities
Diabetes mellitus 1 (5.6) 4 (5.6) NS
Hypertension 4 (22.2) 8 (11.1) NS
Hyperlipidemia 3 (16.7) 6 (8.3) NS
Cardiac disorder 2 (11.1) 3 (4.2) NS
Charlson comorbidity index score > 3 1 (5.9) 1 (1.5) NS
Dengue diagnosis
Probable dengue 1997 11 (61.1) 66 (91.7) 0.005
Probable dengue 2009 with warning signs 15 (83.3) 54 (75.0) NS
Signs & symptoms
Fever 17 (94.4) 68 (94.4) NS
Lethargy 7 (41.2) 22 (32.4) NS
Bleeding gums 1 (5.6) 13 (18.1) NS
Anorexia 10 (55.6) 47 (65.3) NS
Nausea 7 (38.9) 39 (54.2) NS
Vomiting 7 (38.9) 35 (48.6) NS
Diarrhea 7 (38.9) 25 (34.7) NS
Hemorrhagic manifestationsb 4 (22.2) 37 (51.4) 0.032
Any rash 6 (33.3) 40 (55.6) NS
Mucosal bleeding 2 (11.1) 19 (26.4) NS
Gastrointestinal bleeding 0 (0) 3 (4.2) NS
Severe bleedingc 1 (5.6) 4 (5.6) NS
Petechiae 2 (11.8) 23 (33.8) NS
Abdominal pain 8 (44.4) 27 (37.5) NS
Headache 8 (44.4) 32 (44.4) NS
Eye pain 1 (5.6) 1 (1.4) NS
Myalgia 13 (72.2) 49 (68.1) NS
Arthralgia 3 (16.7) 13 (18.1) NS
Duration of fever at presentation (d)d 5 (0e14) 5 (3e7) NS
Pitt bacteremia score  4 5 (29.4) 1 (1.5) 0.006
Temperature (C) 38.4 (36.2e40.8) 37.6 (36.8e39.4) 0.026
Blood pressure (mmHg) 103 (74e140) 108 (90.65e131.8) NS
Pulse rate (/min) 92 (55e166) 88 (63e116.9) NS
a Conditional logistic modeling was performed (only p  0.05 was indicated).
b Bleeding gums, petechiae, ecchymoses, purpura, or bruises.
c Hematemesis, rectal bleeding, or menorrhagia.
d Geometric means are indicated.
Data are presented as n (%) or median (5the95th percentiles).
NS Z not significant.
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+ MODELextracted included white blood cell count, absolute
neutrophil count (ANC), lymphocyte count, platelet count,
albumin, urea, aspartate aminotransferase, and alanine
aminotransferase. DHF and DSS were defined according to
the 1997 WHO guidelines,17 whereas severe dengue was
defined according to the 2009 WHO guidelines.5 Charlson
comorbidity index21,22 and Pitt bacteremia score (PBS)23
were calculated for cases and controls.
Ethics approval
This study was approved by the Domain-Specific Review
Board of the National Healthcare Group, Singapore.
Informed consent from patients was waived.Please cite this article in press as: Thein T-L, et al., Risk factors for
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.Statistical analysis
Categorical variables were described in numbers and per-
centages. Medians and 5the95th percentiles were used in
the descriptive analysis of continuous variables. Univariate
and multivariate logistic regressions were used to calculate
odds ratios (ORs).24 Confounding effect was removed by
performing multivariate logistic regression, adjusted for
potential cofounders identified in univariate analysis. All
statistical analyses were performed using SPSS version 16
(SPSS Inc., Chicago, IL, USA) at a 5% level of significance,
with adjusted ORs and corresponding 95% confidence in-
tervals reported where applicable.concurrent bacteremia in adult patients with dengue, Journal of
1016/j.jmii.2015.06.008
Table 2 Laboratory investigations, treatment modalities, and clinical outcomes of cases and controlsa
Variable Cases (n Z 18) Controls (n Z 72) p
Laboratory investigations at presentation
Leukocyte count (109 cells/L) 4.1 (1.3e28.5) 3.2 (1.46e7.9) NS
Neutrophil count (109 cells/L) 2.9 (0.6e26.4) 1.7 (0.56e5.74) 0.005
Lymphocyte count (109 cells/L) 0.7 (0.2e1.7) 0.9 (0.3e2.94) 0.014
Hematocrit change  20% 43.4 (23.6e53.5) 44.8 (34.82e53.3) NS
Hematocrit change  20% & platelet count < 50,000 cells/L 8 (44.4) 11 (15.3) 0.015
Platelet count (109 cells/L) 55 (17e148) 56 (14.1e150.5) NS
Albumin (g/L) 30 (20e44) 36 (29.2e42) 0.001
Urea (mmol/L) 4.2 (1.3e15.5) 3 (1.38e6.0) NS
Aspartate transaminase (U/L) 135.5 (22e1370) 119 (31e727) NS
Alanine transaminase (U/L) 76 (18e669) 76 (20e445.5) NS
Dengue severity at discharge
Dengue hemorrhagic fever 8 (44.4) 30 (41.7) NS
Dengue shock syndrome 3 (16.7) 1 (1.4) 0.031
Severe dengue 13 (72.2) 13 (18.1) NS
Clinical interventions & outcomes at discharge
Antibiotics 15 (88.2) 8 (11.8) 0.032
Intravenous fluids 18 (100.0) 61 (84.7) NS
Total volume of fluids (mL) 9000 (3040e25,215) 3760 (1000e11,500) 0.002
Duration of fluid therapy (d) 5 (3e12) 3 (1.1e6) 0.016
Blood transfusion 2 (11.1) 2 (2.8) NS
Platelet transfusion 4 (22.2) 9 (12.5) NS
Length of hospitalization (d) 11 (4e88) 4 (2.65e7) 0.002
Intensive care 3 (16.7) 0 (0) NS
Death 3 (16.7) 0 (0) NS
a Conditional logistic modeling was performed (only p  0.05 was indicated).
Data are presented as n (%) or median (5the95th percentiles).
NS Z not significant.
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Among 9,553 patients with dengue, 29 (0.3%) had bacter-
emia. Fifteen patients were subjected to dengue Real-time
Reverse Transcription-Polymerase Chain Reaction, whereas
the remaining 14 patients met the criteria for probable
dengue and had positive results for dengue serology test: 13
were immunoglobulin M-positive and one was immuno-
globulin G-positive. We found four patients, nine patients,
five patients, five patients, and six patients from 2004 to
2008, respectively. The predominant isolated bacteria in
these patients were Staphylococcus aureus [14 of 29
(48.3%)], one of which was a methicillin-resistant strain.
The other bacteria isolated included Salmonella Typhi
(n Z 5), Escherichia coli (n Z 3), Klebsiella pneumoniae
(n Z 2), Streptococcus species (alpha-hemolytic Strepto-
coccus and Streptococcus milleri; n Z 2), Pseudomonas
aeruginosa (nZ 1), Acinetobacter baumannii (n Z 1), and
an unspecified anaerobe. Eighteen (62.1%) cases had their
blood sampled for bacterial growth less than 72 hours after
admission: Staphylococcus aureus (5 of 14), Salmonella
Typhi (4 of 5), and all of the other bacteria except A.
baumannii. Further analyses were performed for these 18
cases versus 72 controls.
Cases and controls were similar in age, sex, and
comorbidities, including Charlson comorbidity index and
duration of fever before presentation to the hospital. AtPlease cite this article in press as: Thein T-L, et al., Risk factors for
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.presentation, significantly fewer cases met the 1997 WHO
criteria for dengue fever [11 (61.1%) cases vs. 66 (91.7%)
controls], but significantly more cases [5 (29.4%)] than
controls [1 (1.5%)] were critically ill (PBS  4). A significant
proportion of cases had higher temperatures (median,
38.4C vs. 37.6C) but lower rates of hemorrhagic mani-
festations at presentation compared with controls [4
(22.2%) vs. 37 (51.4%); Table 1].
For common laboratory results, cases were significantly
more likely than controls tohavehigher neutrophil counts and
lower lymphocyte counts. In addition, cases weremore likely
than controls to have hemoconcentration (hematocrit
change  20%) in association with lower platelet counts
(<50,000 cells/L) and lower serum albumin levels. At the end
of hospitalization, cases were significantly associated with
DSS [3 (16.7%) cases vs. 1 (1.4%) control]. Cases and controls
had similar rates of severe dengue according to the 2009WHO
classification. Not surprisingly, cases received more antibi-
otics, receivedmore fluids (total volume and duration of fluid
therapy), and stayed in the hospital longer than controls
(median, 11 days vs. 4 days; p < 0.01). Three cases required
intensive care admission and subsequently died, whereas
none of the controls needed intensive care or died (Table 2).
Two fatal cases experienced severe dengue shock (the Kleb-
siella case had elevated liver enzymes and the Pseudomonas
case had pneumonia). The last fatal case experienced Sal-
monella septicemia with acute renal involvement.concurrent bacteremia in adult patients with dengue, Journal of
1016/j.jmii.2015.06.008
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cant univariate risk factors, a PBS of 4 (being critically ill)
was found to be independently associated with concurrent
bacteremia in patients with dengue (adjusted OR 14.73,
95% confidence interval 1.30e167.28; Table 3).Discussion
Despite the existence of an integrated dengue prevention
program,25 dengue remains endemic to Singapore. From
2004 to 2008, the number of notified dengue cases was
41,234. Of the notified cases, 28 adults were confirmed to
have died of dengue. Among these confirmed cases of
dengue-related deaths, 14.3% had bacteremia.13 In a mor-
tality study of dengue at the National University Hospital in
Singapore, bacteremia was associated with 44.4% of
dengue-related deaths.11 In another mortality study of
dengue at TTSH, bacteremia was associated with 42.9% of
deaths.12 A study in Taiwan showed that 5.5% of patients
with DHF had bacteremia. Among these patients with
bacteremia, 28.6% did not survive.16 A separate Taiwanese
study identifying clinical and laboratory manifestations of
fatal DHF showed that 37.5% of patients with DHF and
concurrent bacteremia did not survive.10 In our study,
notably, only 16.7% of cases did not survive. The observed
difference in mortality may be attributable to the fact that
Taiwanese patients with bacteremia were older and had
DHF.
In our study, 29 patients [representing a very small
proportion (0.3%) of our cohort from 2004 to 2008] had
bacteremia; among these patients, 18 had concurrent
bacteremia. A recent study at the National University
Hospital in Singapore reported that 10 of 25 isolates from
patients with concurrent bacteremia were primary
bacteremia.26 In our study, all 18 cases had bacteria iso-
lated solely from the bloodstream (without other obvious
sources), indicating primary bacteremia. Fifteen of 18
cases were given antibiotics on the day of blood culture
collection or later during hospitalization. Seven of 18 cases
(39%) were Gram-positive bacteria, and 10 cases (56%) were
Gram-negative bacteria. Among Gram-negative bacteria,
five were Salmonella Typhi cases, representing common
exposure.27 The remaining Gram-negative bacteria were
gastrointestinal tractecommensal, which may be associ-
ated with DSS; however, three of 18 patients had DSS, and
none had gastrointestinal bleeding, which may predispose
to bacterial translocation. A study of the 2010 dengue
outbreak in Sa˜o Paolo, Brazil, documented immuneTable 3 Independent risk factors for concurrent bacter-
emia in patients with dengue at hospital presentationa
Variable Adjusted OR (95% CI) p
Hemorrhagic manifestations 0.35 (0.07e1.75) 0.200
Temperature (C) 1.65 (0.74e3.64) 0.219
Pitt bacteremia score  4 14.73 (1.30e167.28) 0.030
Neutrophil count (109 cells/L) 1.29 (0.94e1.76) 0.115
a Conditional logistic regression modeling was performed.
CI Z confidence interval; OR Z odds ratio.
Please cite this article in press as: Thein T-L, et al., Risk factors for
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.activation and microbial translocation in patients with se-
vere dengue.28
Several hypotheses on the pathogenesis of concurrent
bacteremia in patients with dengue have been formulated.
Antibodies against dengue virus nonstructural protein 1
have been observed to cross-react with endothelial
cells,14,15 resulting in disintegration of endothelial cells via
caspase-dependent apoptosis.14,29 The disintegration of
endothelial cells may have facilitated the entry of bacteria
into the bloodstream of patients with dengue. Another
study revealed that the dengue virus could be isolated in
human leukocytes30 and that the titer of the virus corre-
lated with the severity of the disease.29,31 Lahiri et al11
postulated that leukocyte infection could cause relative
immunosuppression in patients with dengue, contributing
to susceptibility to concurrent bacteremia and high mor-
tality rates in patients with bacteremia, as observed in
previous studies. Consistent with the abovementioned hy-
potheses, a significant proportion of cases in our study had
more events of DSS at hospital discharge.
Although most of the signs and symptoms at presenta-
tion were not significantly different between cases and
controls, a significant proportion of our cases did not pre-
sent with hemorrhagic manifestations. This was not re-
ported in other dengue studies of concurrent bacteremia.
Furthermore, patients with dengue and bacterial infection
were more likely to be critically ill, as defined by the
validated PBS.23 PBS has been shown to be predictive of
mortality in patients with intensive care uniteacquired
sepsis.32 Our results indicated that PBS can be used to
detect the presence of concurrent bacteremia. Neutro-
philia, lymphopenia, and hemoconcentration with signifi-
cant thrombocytopenia may be suggestive as well. See
et al26 reported that patients with dengue and bacterial
infection had higher ANC compared with patients with
dengue without bacterial infection. However, See et al26
reported that patients with dengue and bacterial infec-
tion had lower hematocrit and higher platelet count, con-
trary to our findings. These differences may be attributable
to the inclusion of primary and secondary bacterial in-
fections identified from blood or urine cultures in their
cohort, whereas our study included cases with primary
bacteremia only and our controls were matched on year of
infection and dengue confirmation method. Cases required
more medical resources. It is important to confirm dengue
diagnosis in a timely manner and to triage patients who are
likely to develop bacteremia for closer monitoring and early
intervention.
Our study had several limitations. Its retrospective study
design may have led to some inaccuracy, although our
standardized dengue care path prospectively documented
relevant symptoms and signs, and subjected all patients to
full blood count, renal panel test, and liver panel test
(which were repeated when the initial results yielded
abnormal findings). Blood cultures were ordered as clini-
cally indicated; most patients with confirmed dengue who
did not undergo blood culture recovered without antibiotic
therapy. The small sample size limited the number of var-
iables assessed in the multivariate analysis. We studied
adult patients with dengue who presented to a tertiary care
infectious disease center in a developed country; thus, our
findings and outcomes may not be generalizable to otherconcurrent bacteremia in adult patients with dengue, Journal of
1016/j.jmii.2015.06.008
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+ MODELpopulations (such as children) and settings (community
hospitals and developing countries).
In conclusion, adult patients with dengue and concur-
rent bacteremia and adult patients with dengue without
concurrent bacteremia have few differentiating predictive
factors. Patients with dengue and concurrent bacteremia
are more likely to have DSS, are more likely to be critically
ill, have higher neutrophil count, lower lymphocyte count,
and hemoconcentration with thrombocytopenia at hospital
presentation. A high index of suspicion for bacteremia
among critically ill adult patients with dengue is warranted.
Given the associated mortality, collection of blood cultures
and empiric antibiotic therapy may be considered in pa-
tients who are critically ill.
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